An Orphan Drug Status Granted for the Leading Telormedix’s Cancer Treatment
Telormedix, a clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer…
Telormedix, a clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer…
Alizé Pharma III SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat…
Forbion Capital Partners, the leading Dutch Venture Capital firm investing in world-class healthcare technologies, sold PneumRx of…
Anergis, a company developing proprietary ultra-fast allergy vaccines, closed a Series B financing round totaling 12,1…
Ascendis Pharma, a biotechnology company that applies its innovative TransCon technology to address significant unmet medical…
What could you buy with €1,1M euros? A house? Or a single prescription for a new…
Oxford BioTherapeutics and Menarini Group have initiated the first-in-human clinical study of OBT357, a novel enhanced…
Curetis AG, a developer of next-level molecular diagnostic solutions, has closed a EUR 14.5 million extension of…
Theravalues Corporation, Tokyo based company, will launch Theracurmin® Super for the European market at Hi Europe 2014,…
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment…
The US pharmaceutical company Allergan, known for their Botox, agreed an Actavis bid of 53…
The biotech sector in the Greater Munich area continues to demonstrate significant growth in revenue…